Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines

被引:113
作者
Smith, CC [1 ]
Bennett, PM [1 ]
Pearce, HM [1 ]
Harrison, PI [1 ]
Reynolds, DJM [1 ]
Aronson, JK [1 ]
GrahameSmith, DG [1 ]
机构
[1] UNIV OXFORD,RADCLIFFE INFIRM,DEPT CLIN PHARMACOL,OXFORD OX2 6HE,ENGLAND
关键词
adverse drug reactions; Committee on Safety of Medicines; yellow cards;
D O I
10.1111/j.1365-2125.1996.tb00004.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have retrospectively analysed data collected by a local adverse drug reactions reporting scheme in an acute hospital medical setting and have determined the numbers and types of reactions that would have merited notification as yellow card reports according to the guidelines of the Committee on Safety of Medicines. 2 The data related to 20 695 consecutive acute general medical admissions on seven general medical wards (140 beds) and were collected over 3 years, from April 1990 to March 1993. 3 Over 3 years there were 1420 reports of suspected adverse drug reactions, a rate of 68.7 per 1000 admissions. 4 If the guidelines for reporting issued by the Committee on Safety of Medicines had been strictly followed, 477 yellow cards would have been sent (23.1 per 1000 admissions). In 357 of these reports (74.8%), the reaction had caused admission to hospital. Only 31 of the 477 potential cards (6.5%) involved black triangle drugs and 10 of these were for minor reactions. 5 Only 30 of the 477 potential yellow cards (6.3%) were known to have been sent. The majority of those reactions not reported were for drug-related admissions, most of which were for well-known reactions to established drugs. 6 We have confirmed and quantified the extent of under-reporting of serious suspected adverse drug reactions to the Committee on Safety of Medicines from our hospital medical unit.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 20 条
  • [1] BATEMAN DN, 1992, BRIT J CLIN PHARMACO, V34, P421
  • [2] ATTITUDINAL SURVEY OF ADVERSE DRUG REACTION REPORTING BY MEDICAL PRACTITIONERS IN THE UNITED-KINGDOM
    BELTON, KJ
    LEWIS, SC
    PAYNE, S
    RAWLINS, MD
    WOOD, SM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (03) : 223 - 226
  • [3] BOOTH NJ, 1989, THESIS U WALES
  • [4] BOOTH NJ, 1988, PHARM J, V241, pR3
  • [5] DRUG-RELATED HOSPITAL ADMISSIONS
    EINARSON, TR
    [J]. ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) : 832 - 840
  • [6] SURVEY OF THE SPONTANEOUS ADVERSE DRUG REACTION REPORTING SCHEMES IN 15 COUNTRIES
    GRIFFIN, JP
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 : S83 - S100
  • [7] DRUG RELATED ADMISSIONS TO MEDICAL WARDS - A POPULATION BASED SURVEY
    HALLAS, J
    GRAM, LF
    GRODUM, E
    DAMSBO, N
    BROSEN, K
    HAGHFELT, T
    HARVALD, B
    BECKNIELSEN, J
    WORM, J
    JENSEN, KB
    DAVIDSEN, O
    FRANDSEN, NE
    HAGEN, C
    ANDERSEN, M
    FROLUND, F
    KROMANNANDERSEN, H
    SCHOU, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (01) : 61 - 68
  • [8] REASONS FOR DISAGREEMENT IN THE STANDARDIZED ASSESSMENT OF SUSPECTED ADVERSE DRUG-REACTIONS
    HUTCHINSON, TA
    FLEGEL, KM
    HOPINGKONG, H
    BLOOM, WS
    KRAMER, MS
    TRUMMER, EG
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (04) : 421 - 426
  • [9] LARMOUR I, 1991, Australian Journal of Hospital Pharmacy, V21, P90
  • [10] THE YELLOW CARD - MARK .2.
    LAWSON, DH
    [J]. BRITISH MEDICAL JOURNAL, 1990, 301 (6763) : 1234 - 1234